Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-09-26T00:15:37.929Z.
Calculation as of: 2026-09-26T00:15:37.929Z.
Quote observation: 2026-09-25T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 37d2477c1f16d013e6015aa776ccab1476fada05dcae8101118db9c320bf6438
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$62.74B
EBITDA Yield
1.19%
TTM Avg
2.53%
3Y Avg
4.64%
5Y Avg
5.02%
Market Cap
$50.08B
EBITDA Yield
14.98%
TTM Avg
12.18%
3Y Avg
14.84%
5Y Avg
14.84%
Market Cap
$64.90B
EBITDA Yield
3.99%
TTM Avg
3.13%
3Y Avg
3.11%
5Y Avg
3.84%
Market Cap
$71.85B
EBITDA Yield
18.39%
TTM Avg
15.79%
3Y Avg
17.48%
5Y Avg
17.90%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CRH plc (CRH) | $56.82B | N/A | N/A | N/A | N/A |
| Nucor Corporation (NUE)vs › | $56.31B | 9.18% | 8.87% | 13.30% | 18.50% |
| Vale S.A. (VALE)vs › | $58.04B | 20.89% | 16.71% | 22.71% | 25.49% |
| Corteva, Inc. (CTVA)vs › | $52.52B | 7.78% | 7.71% | 7.83% | 7.54% |
| Air Products and Chemicals, Inc. (APD)vs › | $62.74B | 1.19% | 2.53% | 4.64% | 5.02% |
| AngloGold Ashanti plc (AU)vs › | $50.08B | 14.98% | 12.18% | 14.84% | 14.84% |
| Wheaton Precious Metals Corp. (WPM)vs › | $64.90B | 3.99% | 3.13% | 3.11% | 3.84% |
| Barrick Mining Corporation (B)vs › | $71.85B | 18.39% | 15.79% | 17.48% | 17.90% |
| Ecolab Inc. (ECL)vs › | $78.66B | 4.19% | 4.16% | 4.35% | 4.36% |
| Nutrien Ltd. (NTR)vs › | $34.67B | 14.07% | 13.17% | 13.19% | 14.99% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute